7 - Geriatric Pharmacotherapy Flashcards

1
Q

What is the problem with the increase in chronic conditions in the elderly?

A

People are living longer, having more diseases, and having more meds. These factors result in many drug interactions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What percent of elderly patients are taking at least one Rx medication?

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are important factors to think about when discussing meds with elderly patients?

A
  • Make sure that you ask if they are actually taking their meds
  • Tell them they can contact you if they are having trouble with the meds before they stop them.
  • Think about what meds you can stop because they no longer need them or they are not effective
  • Cost
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

True/False

One in six hospital admissions is due to an adverse drug event.

A

True!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the most common medications that result in an adverse drug event in an elderly patient?

A

Anti-thrombotics, diuretics, NSAIDs, and

anti-diabetic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What factors should you consider for therapeutic goals?

A

What are the patient’s goals?
What are your goals for the patient?

Independence
Physical function
Mobility
Activities of daily living
Instrumental activities of daily living
Health-related quality of life (HRQOL)
Patient’s perception of how health impacts their physical, social, and psychologic functioning and well-being 
Longevity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define Pharmacokinetics (PK).

A

“What the body does to the drug”

Absorption, Distribution, Metabolism, and Elimination (ADME)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

True/False

Due to age-related changes PK parameters can change dramatically for some drugs.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is likely the most important factor in the age related change in PK?

A

Reduced renal function is likely the most relevant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does absorption change in the elderly?

A

Unchanged passive diffusion (most drugs)
↓ active transport, ↓ bioavailability (some drugs)
↓ first-pass metabolism, ↑ bioavailability (some drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does distribution change in the elderly?

A

Water-soluble: ↓ Vd and ↑ plasma concentration

Lipid-soluble: ↑ Vd and ↑ t ½

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does metabolism change in the elderly?

A

↓ hepatic metabolism and ↑ t ½ (some drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does elimination change in the elderly?

A

↓ clearance and ↑ t ½ of renally eliminated drugs and/or active metabolites (many drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the Cockcroft-Gault Equation used for?

A

Assessing renal function (GFR)

look at this slide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the MDRD Equation used for?

A

Assessing renal function (GFR)

Takes into account age, SCr, gender, ethnicity, BUN, albumin, and body surface area
Need more lab values, equation is much more complex
May be more accurate than Cockcroft-Gault

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Define Pharmacodynamics.

A

What the drug does to the body

  • Both therapeutic effects and side effects
  • Ex: Anticoagulants, antiplatelets, sedatives, antihypertensives, antidiabetics, etc.

** Remember: Elderly may be more sensitive to the effects of medications

17
Q

Why do we “start low, go slow”? What does it mean?

A

Start at a lower dose and titrate up slowly

Can help mitigate the consequences of PK and PD changes

18
Q

Define Polypharmacy.

A

Use of multiple drugs or the administration of more medications than are indicated clinically

19
Q

Polypharmacy occurs in ___% of older patients.

A

Approximately 50-60% of older outpatients

20
Q

What are complications of polypharmacy?

A

May lead to drug-drug and/or drug-disease interactions:
Increase risk for side effects
Multiple providers
OTCs

21
Q

How can we help prevent/decrease polypharmacy?

A

Avoid treating side effects with another drug

Ask about dietary supplements because they increase polypharmacy:
Vitamins, minerals, and herbal products (often not included on medication records)

22
Q

Define Underuse.

A

Omission of drug therapy that is indicated for the treatment or prevention of a disease and/or condition
“Gap(s) in therapy”
Consider non-adherence as potential source for underuse

23
Q

What are some drugs that are commonly underused?

A

Commonly include bisphosphonates, anticoagulants, antiplatelets, antihypertensives, statins
Highly dependent on comorbid disease states and PMH
Consider rescue medications as well (albuterol, nitroglycerin, etc.)

24
Q

Define Inappropriate use.

What are the problems that arise?

A

Prescribing medications outside the bounds of acceptable medical standards

  • Different than “off-label use”
  • Inappropriate drug, dose, or duration

Can lead to drug-drug or drug-disease interactions
Consider renal dose adjustments

25
Q

How can we help decrease inappropriate use? What are some tools we can use?

A

Beers List and STOPP/START may help guide selection of appropriate agents

Assess OTC, herbal, and other potential sources of medications

26
Q

What should you think about when doing a medication assessment?

A

Determine tx goals first!
Patient’s age and renal status
drug/drug interactions (including supp/OTC)
drug/disease interactions
Accurate and complete PMH and medication list
Allergies
Compliance (find out why if it is an issue)

**Counsel patient and reassess often!

27
Q

Describe drug-drug interactions:

A

Can increase/decrease therapeutic effects or side effects

Can occur between prescription drugs and OTC products

Additive or synergistic

28
Q

Describe drug-disease interactions:

A

Side effect/therapeutic effect of one drug may worsen another disease

Most interactions are due to the therapeutic effects as opposed to rare side effects

29
Q

What is the BEERS List?

A

A guide for practitioners when choosing medications for patients.

Three categories of recommendations:
Medications to avoid regardless of indication
Medications to be avoided if certain disease(s) are present
Medications to be used cautiously in older adults

30
Q

What drugs should be avoided in elderly people if at all possible? Why?

(think of the ones we talked about a lot!)

A

Drugs with anticholinergic burden

Can cause sedation, confusion, mental clouding, delirium, memory problems, difficulty concentrating, urinary retention, constipation, dry-mouth, tachycardia, falls

  • Elderly tend to be more sensitive to these effects
  • If use cannot be avoided, limit use of other potential problem agents
31
Q

What are some other medications to be avoided (according to the Beers criteria)?

A
Digoxin
Antispasmotics
Alpha1 blockers 
Central alpha blockers 
Tertiary TCAs
Antipsychotics
Barbituates
Benzodiazepines 
Non-benzodiaz-epine hypnotics
Insulin - sliding scale
Sulfonylureas, long-acting
NSAIDS
Muscle relaxants
32
Q

What are some other medications to be used cautiously (according to the Beers criteria)?

A
Aspirin for primary prevention of cardiac events
Prasugrel
Dabigatran
Antipsychotics 
Vasodilators
33
Q

Beers vs. STOP/START

just review

A

Both offer advantages:
Medications to avoid (both)
START/STOPP also recommend alternatives
Both relatively evidenced-based
STOPP may better identify avoidable problems
Beers List only requires medication review; START/STOPP also require lab values

Both have disadvantages:
Neither has proven to improve overall outcomes (mortality)
Neither discuss appropriate medications used inappropriately

34
Q

True/False

Use of combination tablets and long-acting formulations is not recommended for elderly patients.

A

False

Use of combination tablets and long-acting formulations may overcome some compliance issues.

35
Q

What is a resource you can refer to in addition to Beers and START/STOP criteria that is especially helpful in managing elderly medications?

A

Your local pharmacist!!

36
Q

Done! Rocked it!

A

I cut out material that went beyond our objectives =)